已收盘 02-06 16:00:00 美东时间
+2.710
+3.39%
华盛资讯2月6日讯,芬塔公司公布2025财年Q4业绩,公司Q4营收15.66亿美元,同比增长21.7%,归母净利润0.70亿美元,同比增长22.8%。
02-06 13:50
Ventas (NYSE:VTR) is looking for FY2026 Normalized FFO of $3.78-$3.88 vs $3.77 analyst estimate..
02-06 06:40
The Q4 earnings report for Ventas (NYSE:VTR) was released on Thursday, February...
02-06 05:14
Ventas (NYSE:VTR) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.88 by 1.02 percent. This is a 9.88 percent increase over earnings of $0.81 per share from the same period
02-06 05:14
Ventas (NYSE:VTR) is gearing up to announce its quarterly earnings on Thursday,...
02-05 01:22
Revolution Medicines涨17.38%;Rocket Companies, Inc. Class A涨6.64%;帕尔迪涨3.60%
01-09 07:11
Elanco Animal Health涨1.73%;Revolution Medicines涨1.55%;加拿大帝国商业银行涨1.52%
2025-12-27 07:10
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
2025-12-05 08:35
Keybanc analyst Todd M. Thomas maintains Ventas (NYSE:VTR) with a Overweight and raises the price target from $70 to $85.
2025-12-04 21:20
Ventas Inc's (NYSE:VTR) short interest as a percent of float has risen 5.0% sin...
2025-11-27 23:00